AZD1222
D8111C00010
Approved mab terminated
Quick answer
AZD1222 for COVID-19, SARS-CoV-2 is a Approved program (mab) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- COVID-19, SARS-CoV-2
- Phase
- Approved
- Modality
- mab
- Status
- terminated